Wells Fargo’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.34M | Buy |
147,135
+26,354
| +22% | +$572K | ﹤0.01% | 3154 |
|
|
2025
Q4 | $3.17M | Buy |
120,781
+87,329
| +261% | +$2.27M | ﹤0.01% | 3069 |
|
|
2025
Q3 | $756K | Sell |
33,452
-14,028
| -30% | -$289K | ﹤0.01% | 4005 |
|
|
2025
Q2 | $944K | Sell |
47,480
-30,053
| -39% | -$586K | ﹤0.01% | 3724 |
|
|
2025
Q1 | $1.31M | Buy |
77,533
+63,523
| +453% | +$1.08M | ﹤0.01% | 3480 |
|
|
2024
Q4 | $259K | Buy |
14,010
+2,489
| +22% | +$48.6K | ﹤0.01% | 4640 |
|
|
2024
Q3 | $250K | Buy |
11,521
+630
| +6% | +$14.1K | ﹤0.01% | 4430 |
|
|
2024
Q2 | $214K | Buy |
10,891
+598
| +6% | +$12.5K | ﹤0.01% | 4478 |
|
|
2024
Q1 | $223K | Buy |
10,293
+302
| +3% | +$7.5K | ﹤0.01% | 4404 |
|
|
2023
Q4 | $289K | Buy |
9,991
+1,130
| +13% | +$30.2K | ﹤0.01% | 4239 |
|
|
2023
Q3 | $237K | Sell |
8,861
-4,371
| -33% | -$149K | ﹤0.01% | 4251 |
|
|
2023
Q2 | $490K | Buy |
13,232
+3,894
| +42% | +$136K | ﹤0.01% | 3957 |
|
|
2023
Q1 | $292K | Buy |
9,338
+3,283
| +54% | +$106K | ﹤0.01% | 4203 |
|
|
2022
Q4 | $180K | Sell |
6,055
-345
| -5% | -$12.3K | ﹤0.01% | 4227 |
|
|
2022
Q3 | $244K | Sell |
6,400
-7,457
| -54% | -$374K | ﹤0.01% | 4125 |
|
|
2022
Q2 | $755K | Sell |
13,857
-19,745
| -59% | -$1.09M | ﹤0.01% | 3475 |
|
|
2022
Q1 | $2.1M | Sell |
33,602
-28,722
| -46% | -$1.89M | ﹤0.01% | 3247 |
|
|
2021
Q4 | $6.27M | Buy |
62,324
+9,482
| +18% | +$833K | ﹤0.01% | 2340 |
|
|
2021
Q3 | $4.75M | Sell |
52,842
-5,241
| -9% | -$476K | ﹤0.01% | 2874 |
|
|
2021
Q2 | $5.36M | Sell |
58,083
-5,691
| -9% | -$454K | ﹤0.01% | 2807 |
|
|
2021
Q1 | $6.16M | Buy |
63,774
+6,465
| +11% | +$667K | ﹤0.01% | 2646 |
|
|
2020
Q4 | $2.98M | Buy |
57,309
+5,277
| +10% | +$221K | ﹤0.01% | 3195 |
|
|
2020
Q3 | $2.08M | Buy |
52,032
+28,180
| +118% | +$882K | ﹤0.01% | 3278 |
|
|
2020
Q2 | $382K | Buy |
23,852
+14,503
| +155% | +$222K | ﹤0.01% | 4511 |
|
|
2020
Q1 | $100K | Sell |
9,349
-823
| -8% | -$11.5K | ﹤0.01% | 5054 |
|
|
2019
Q4 | $131K | Buy |
+10,172
| New | +$121K | ﹤0.01% | 5176 |
|
|
2018
Q2 | – | Sell |
-500
| Closed | -$2K | – | 6398 |
|
|
2018
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 6192 |
|
|
2017
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 6186 |
|
|
2017
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 6148 |
|
|
2017
Q2 | $3K | Sell |
500
-10,230
| -95% | -$82.5K | ﹤0.01% | 6001 |
|
|
2017
Q1 | $118K | Buy |
10,730
+10,230
| +2,046% | +$121K | ﹤0.01% | 5125 |
|
|
2016
Q4 | $6K | Buy |
+500
| New | +$4.72K | ﹤0.01% | 5913 |
|
Other funds holding FLGT
RI
VCM
ICM
Wells Fargo's FLGT Position: Q1 2026 in Review
Wells Fargo increased its Fulgent Genetics (FLGT) stake by 22% in Q1 2026, buying an estimated $572K and bringing the position to 147,135 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3154.
Wells Fargo first reported a position in FLGT in Q4 2016 and has held it in 32 quarters since. The position peaked at $6.27M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.
- Wells Fargo held 147,135 shares of Fulgent Genetics worth $2.34M as of Q1 2026.
- Wells Fargo bought 26,354 Fulgent Genetics shares in Q1 2026, an estimated $572K.
- Fulgent Genetics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3154 holding.
- Wells Fargo first reported a position in Fulgent Genetics in Q4 2016 and has held it in 32 quarters since.
- Wells Fargo's Fulgent Genetics position peaked at $6.27M in Q4 2021.
- 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.